Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2

Conditions

Neuroblastoma 2

Interventions

Specimen Handling 189Magnetic Resonance Spectroscopy 150pembrolizumab 147Carboplatin 110Biopsy 106Cyclophosphamide 92Cisplatin 85Paclitaxel 76Bevacizumab 68Gemcitabine 67Nivolumab 59fludarabine 56Fluorouracil 52Radiotherapy 49Capecitabine 49Pemetrexed 45Dexamethasone 45Oxaliplatin 44Rituximab 43Leucovorin 43atezolizumab 42Docetaxel 41venetoclax 39Doxorubicin 39durvalumab 37Temozolomide 32Standard of Care 32Radiation 32Prednisone 32Cetuximab 31

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × saponin QA-21V1 × 30 days × Clear all
NCT06057948 2026-06-05

A Study of a Vaccine in Combination With Beta-glucan in People With Neuroblastoma

Memorial Sloan Kettering Cancer Center

Phase 2 Recruiting
94 enrolled
CNS

Neuroblastoma

NCT04936529 2026-05-07

A Study of a Vaccine in Combination With β-glucan and GM-CSF in People With Neuroblastoma

Memorial Sloan Kettering Cancer Center

Phase 2 Recruiting
286 enrolled
CNS

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡